Developments in Securities Fraud Class Actions Against U.S. Life Sciences Companies
Harvard Corporate Governance
MARCH 20, 2023
Posted by David Kistenbroker, Joni S. Jacobson and Angela M. Liu, Dechert LLP, on Monday, March 20, 2023 Editor's Note: David Kistenbroker , Joni S. Jacobson and Angela M. Liu are Partners at Dechert LLP. This post is based on a Dechert memorandum by Mr. Kistenbroker, Ms. Jacobson, Ms. Liu, Christine Isaacs and Biaunca S. Morris. In 2022, the total number of securities class action complaints filed remained below the more elevated levels we saw during 2017-2020, but life sciences companies were
130 130
Let's personalize your content